Direkt zum Inhalt
Merck
  • Synthesis, antiproliferative activity and inhibition of tubulin polymerization by anthracenone-based oxime derivatives.

Synthesis, antiproliferative activity and inhibition of tubulin polymerization by anthracenone-based oxime derivatives.

European journal of medicinal chemistry (2010-06-16)
Georg Surkau, Konrad J Böhm, Klaus Müller, Helge Prinz
ZUSAMMENFASSUNG

A series of anthracenone-based oxime ethers and -esters were synthesized in order to evaluate their antiproliferative activity. Several investigated compounds displayed strong antiproliferative activity against K562 leukemia cells and proved to be strong inhibitors of tubulin polymerization. In this context, anthracenone-based oxime ethers and -esters are considered to contribute to the development of novel antiproliferative drugs, based on tubulin interaction.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Doxorubicin -hydrochlorid, 98.0-102.0% (HPLC)
Sigma-Aldrich
Colchicin, ≥95% (HPLC), powder
Sigma-Aldrich
Nocodazol, ≥99% (TLC), powder
Sigma-Aldrich
Doxorubicin -hydrochlorid, suitable for fluorescence, 98.0-102.0% (HPLC)
Sigma-Aldrich
Colchicin, suitable for plant cell culture, BioReagent, ≥95% (HPLC)
Sigma-Aldrich
Vinblastin -sulfat (Salz), 96-102% (HPLC)
Sigma-Aldrich
Podophyllotoxin